Clinical Trial

NOPE37: Angiogenic Factors for Managing Term Preeclampsia

Study acronym: NOPE37
Recruiting
View on ClinicalTrials.gov →
Summary
This study tests the hypothesis that, in women with preeclampsia without severe features, delivery management based on sFlt-1/PlGF would reduce the rate of induction of labor without worsening the rate of progression to preeclampsia with severe features and other maternal complications.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-25; most recent amendment 2025-12-04.
Status change: Not Yet Recruiting → Recruiting 2025-12-04
Trial Details
NCT Number NCT07193680
Lead Sponsor Hospital Universitari Vall d'Hebron Research Institute
Collaborators: Instituto de Salud Carlos III
Conditions Preeclampsia
Enrollment 750 participants
Start Date 2025-12-04
Primary Completion 2027-12 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2025-12-11